{"id":"NCT03296072","sponsor":"GlaxoSmithKline","briefTitle":"In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste","officialTitle":"A Randomized, Examiner Blind, Crossover, in Situ Erosion Study to Investigate the Efficacy of an Experimental Dentifrice in Remineralization of Previously Softened Enamel Compared to a Placebo Dentifrice","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-11-13","primaryCompletion":"2018-01-16","completion":"2018-01-16","firstPosted":"2017-09-28","resultsPosted":"2019-02-20","lastUpdate":"2020-09-16"},"enrollment":62,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Tooth Erosion"],"interventions":[{"type":"DRUG","name":"0.254% w/w sodium fluoride and 5% KNO3","otherNames":[]},{"type":"DRUG","name":"0.454% w/w stannous fluoride","otherNames":[]},{"type":"DRUG","name":"5% KNO3","otherNames":[]}],"arms":[{"label":"Test product","type":"EXPERIMENTAL"},{"label":"Comparator Product","type":"ACTIVE_COMPARATOR"},{"label":"Placebo Product","type":"PLACEBO_COMPARATOR"}],"summary":"This will be a randomized, controlled, single center, single- blind, 3 period, 3 treatment, cross-over, in situ design which consists of placing pre-eroded bovine enamel specimens intra orally using a palatal appliance and testing the remineralizing performance of the experimental (dentifrice containing 0.254 Percent weight by weight \\[%, w/w\\] sodium fluoride (1150 parts per million \\[ppm\\] fluoride) and 5% KNO3 \\[potassium nitrate\\]), comparator (dentifrice containing 0.454% w/w stannous fluoride (1100 ppm fluoride) and placebo (Fluoride free placebo containing 5% KNO3 \\[0 ppm fluoride\\] ) dentifrices 2 and 4 hours (hrs) post treatment application, based on surface micro hardness measurements. This study will be carried out in healthy adults with a maxillary dental arch suitable for the retention of the palatal appliance.","primaryOutcome":{"measure":"% Surface Micro Hardness Recovery (SMHR; Comparison of 1150 Ppm Fluoride and 5% KNO3 Dentifrice Relative to a Fluoride Free Placebo Dentifrice to Enhance Remineralization of Enamel)","timeFrame":"After 4 hrs following single exposure of treatment","effectByArm":[{"arm":"Test Product","deltaMin":29.67,"sd":1.12},{"arm":"Placebo Product","deltaMin":21.98,"sd":1.12}],"pValues":[{"comp":"OG000 vs OG001","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":9,"exclusionCount":12},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["32303206"],"seeAlso":["https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217381&amp;parentIdentifier=208166&amp;attachmentIdentifier=2023405a-a4d3-4a83-81a3-646cce348c22&amp;fileName=gsk-208166-protocol-redact.pdf&amp;versionIdentifier=","https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217381&amp;parentIdentifier=208166&amp;attachmentIdentifier=6d21b0dc-6a7f-469f-9dd7-40aeb2f0005d&amp;fileName=gsk-208166-reporting-and-analysis-plan-redact.pdf&amp;versionIdentifier="]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":62},"commonTop":["Oral Mucosal Erthyema","Nasopharyngitis","Toothache","Dental caries","Lip haematoma"]}}